NCT03739853View on ClinicalTrials.gov

Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

May 14, 2019

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Psoriatic Arthritis
Interventions
DRUG

Methotrexate

Used in all three arms of study

DRUG

Sulfasalazine

Used in arm 2 of study

DRUG

Leflunomide

Used in arm 2 of study

DRUG

Adalimumab

Used in arm 3 of the study only

Trial Locations (1)

OX3 7LD

Oxford University Hospitals NHS Trust, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT03739853 - Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial | Biotech Hunter | Biotech Hunter